FATE vs PEG · rev $13.6M vs P/E 18, rev $10.29B
Fate Therapeutics Inc (FATE) versus Public Service Enterprise Group Inc (PEG) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Latest reported FATE revenue for 2024-12-31 was $13.6M. Net income was -$186.3M. Revenue was down 78.5% from 2023-12-31 to 2024-12-31. FATE currently screens at market cap $331.0M.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
FATE currently screens at market cap $331.0M. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Not investment advice. Open the FATE and PEG stock pages for the full models.
Not investment advice.